Merrimack Pharmaceuticals Inc (MACK)

5.18 -0.03  -0.58% NASDAQ Aug 5, 14:50 USD
View Full Chart
Price Chart
View All MACK News

News

View All Events

Events

Date Type Description
08/06/2021 Earnings Results Q2 2021 Earnings Results
06/10/2021 10:00 EST AGM 2020 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
03/10/2021 Earnings Results Q4 2020 Earnings Results
11/05/2020 Earnings Results Q3 2020 Earnings Results
08/07/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.
  • URL: http://www.merrimack.com
  • Investor Relations URL: http://investors.merrimackpharma.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Aug. 06, 2021
  • Last Earnings Release: May. 06, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Dec. 13, 2019

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.